Simulations Plus, Inc. (NASDAQ:SLP) Receives Consensus Recommendation of “Reduce” from Brokerages

Shares of Simulations Plus, Inc. (NASDAQ:SLP) have been assigned an average rating of “Reduce” from the eight ratings firms that are presently covering the stock, Marketbeat Ratings reports. One analyst has rated the stock with a sell rating and seven have given a hold rating to the company. The average 12-month price objective among brokers that have updated their coverage on the stock in the last year is $17.25.

Several analysts recently weighed in on the company. Wall Street Zen lowered Simulations Plus from a “buy” rating to a “hold” rating in a research note on Saturday, June 13th. Weiss Ratings raised shares of Simulations Plus from a “sell (d)” rating to a “sell (d+)” rating in a report on Friday, July 10th. Craig Hallum cut shares of Simulations Plus from a “buy” rating to a “hold” rating and set a $18.50 target price on the stock. in a research note on Thursday, June 18th. Finally, William Blair cut Simulations Plus from an “outperform” rating to a “market perform” rating in a report on Wednesday, June 17th.

Institutional Inflows and Outflows

Several large investors have recently bought and sold shares of the stock. First Light Asset Management LLC raised its stake in Simulations Plus by 6.1% during the second quarter. First Light Asset Management LLC now owns 2,792,677 shares of the technology company’s stock worth $51,134,000 after buying an additional 159,854 shares during the last quarter. BlackRock Inc. bought a new position in shares of Simulations Plus in the 2nd quarter worth about $27,503,000. Royce & Associates LP lifted its stake in shares of Simulations Plus by 15.4% in the 4th quarter. Royce & Associates LP now owns 402,416 shares of the technology company’s stock valued at $7,336,000 after purchasing an additional 53,658 shares during the period. Kennedy Capital Management LLC boosted its position in shares of Simulations Plus by 7.8% during the 4th quarter. Kennedy Capital Management LLC now owns 398,902 shares of the technology company’s stock valued at $7,272,000 after purchasing an additional 28,717 shares in the last quarter. Finally, Meros Investment Management LP acquired a new stake in Simulations Plus during the fourth quarter worth approximately $6,184,000. 78.08% of the stock is owned by institutional investors.

Simulations Plus Stock Up 0.3%

Shares of Simulations Plus stock opened at $18.49 on Friday. Simulations Plus has a 12-month low of $11.09 and a 12-month high of $21.01. The company has a market capitalization of $374.05 million, a price-to-earnings ratio of 46.22 and a beta of 1.31. The firm’s 50-day moving average price is $18.39 and its two-hundred day moving average price is $16.47.

Simulations Plus (NASDAQ:SLP) last issued its quarterly earnings results on Thursday, July 9th. The technology company reported $0.30 earnings per share for the quarter, topping analysts’ consensus estimates of $0.23 by $0.07. The company had revenue of $21.89 million during the quarter, compared to the consensus estimate of $20.90 million. Simulations Plus had a net margin of 9.88% and a return on equity of 13.50%.

About Simulations Plus

Simulations Plus, Inc develops software and provides consulting services for pharmaceutical and biotechnology companies involved in drug discovery and development. Its modeling and simulation tools are designed to help researchers evaluate drug candidates, understand how medicines move through the body, assess safety risks and support decisions throughout the development process.

The company’s products include GastroPlus, a platform used for physiologically based pharmacokinetic and biopharmaceutic modeling; ADMET Predictor, which helps predict absorption, distribution, metabolism, excretion and toxicity characteristics; and DILIsym, a software platform focused on drug-induced liver injury.